Copyright
©The Author(s) 2023.
World J Hepatol. Nov 27, 2023; 15(11): 1226-1236
Published online Nov 27, 2023. doi: 10.4254/wjh.v15.i11.1226
Published online Nov 27, 2023. doi: 10.4254/wjh.v15.i11.1226
(n = 60) | DAFD ratio (95%CI) |
Group assignment (protocol) | 0.78 (0.39, 1.56) |
Deep sedation (yes) | 0.89 (0.39, 2.02) |
Gastrointestinal bleeding (yes) | 0.65 (0.32, 1.31) |
MELD-Na (per unit increase) | 0.97 (0.94, 1.01) |
Mechanical ventilation duration (per day) | 0.79 (0.72, 0.87) |
- Citation: Ward JA, Yerke J, Lumpkin M, Kapoor A, Lindenmeyer CC, Bass S. Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy. World J Hepatol 2023; 15(11): 1226-1236
- URL: https://www.wjgnet.com/1948-5182/full/v15/i11/1226.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i11.1226